PubMed Health⌕ Search

Biomedical subjects

B Stenström

Publications and source records attributed to B Stenström.

26 records · Page 2Linked to original sources

Radiation absorbed doses at radiographic examination of third molars.

The radiation absorbed doses to critical organs, i.e. the thyroid and salivary glands and the gonadal region, were measured at radiographic examination of third molars. A tissue equivalent phantom was used together with ionization chamber detectors and TLDs. In the maxilla three, and in the mandible four different projections were used; also an extraoral lateral view. The greatest thyroid dose, 35 muGy, came from a mandibular disto-oblique projection with the circular tube collimator and Ultra-Speed film. the thyroid dose from an extraoral lateral view with high sensitivity screens was 3.7 muGy. The doses in different parts of the parotid gland from the disto-oblique mandibular projection with Ultra-Speed film ranged between 2.65 and 0.052 mGy. The corresponding doses in the submandibular gland were 1.74 mGy beneath the mandible and 0.458 mGy in the fovea. A rectangular tube collimator reduced the doses by approximately 50%. the Ekta-Speed film required approximately 40% lower exposure than the Ultra-Speed film. Without shielding the gonadal doses from a complete examination of four third molars were of the same order of magnitude as from a full survey with intraoral films, i.e. 3-7 muGy. A horizontal radiation shield reduced the thyroid doses by between 12 and 46% and the gonadal doses by between 50 and 95%. The reduction effect from the shield was relatively greater when using the larger aperture of the tube collimator. Combinations of leaded aprons and soft leaded collars reduced the thyroid doses by between 15 and 42% and the gonadal doses by two orders of magnitude.

Gonads↗

A comparison of the pharmacokinetic properties of three estradiol esters.

In order to assess the pharmacokinetics properties of estradiol cypionate, valerate and benzoate, the daily plasma levels of estradiol and estrone were analysed in groups of 10, 9 and 10 subjects, respectively, before and during 3 weeks after the intramuscular administration of a single dose of 5.0 mg in 1.0 ml arachis oil. In order to minimize the contribution of endogenous estrogens to the plasma levels, all subjects were receiving a combined oral contraceptive consisting of levonorgestrel (150 micrograms) and ethinyl estradiol (30 micrograms) for three months prior to the study and during the study period. The administration of estradiol cypionate gave significantly lower peak levels of estradiol and estrone than that of the valerate and benzoate. Peak plasma levels of estradiol and estrone were reached in approximately 4 days following the administration of estradiol cypionate and in a significantly shorter time (approximately 2 days) following the administration of both the valerate and benzoate. One hour after the injection of the esters, the average percentage increases in plasma estradiol and estrone levels were significantly higher in the valerate and benzoate groups compared to the subjects receiving estradiol cypionate. The average duration of elevated estrogen levels was shortest in the benzoate group (4-5 days) followed by the valerate (7-8 days) and cypionate (approximately 11 days). In none of the subjects studied were elevated estradiol and/or estrone levels encountered 2 weeks after the injection of the various esters. The data suggests that among the three esters studied, the valerate provides the most predictable pharmacokinetic behaviour.

Adult↗